Teladoc Health, Inc. (TDOC) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Teladoc Health, Inc. (TDOC) Healthcare & Pipeline Overview

Teladoc Health, Inc. delivers virtual healthcare services globally, offering a comprehensive portfolio of solutions for episodic, chronic, and complex medical conditions. Operating under brands like Teladoc, Livongo, and BetterHelp, the company connects individuals and organizations with remote healthcare, positioning itself in the expanding telehealth market.

What Is the Investment Thesis for TDOC?

Teladoc Health operates in the growing telehealth market, driven by increasing demand for convenient and accessible healthcare solutions. The company's comprehensive service portfolio, covering episodic, chronic, and mental health needs, positions it to capture a significant share of this expanding market. However, Teladoc's profitability remains a concern, with a negative profit margin of -6.8%. Key value drivers include expanding its service offerings, increasing member engagement, and achieving economies of scale. Upcoming catalysts include potential partnerships with major healthcare providers and expansion into new international markets. Investors should monitor the company's ability to improve its financial performance and navigate the competitive landscape.

Based on FMP financials and quantitative analysis

TDOC Key Highlights

Market capitalization of $1.18B reflects investor valuation of Teladoc Health's future growth potential in the telehealth sector.

• Gross margin of 65.6% indicates a strong ability to manage the cost of delivering virtual healthcare services.
• Beta of 2.08 suggests high volatility compared to the broader market, reflecting the growth-oriented nature of the telehealth industry.
• The company serves a diverse range of clients, including employers, health plans, and individual members, providing a stable revenue base.
• Teladoc Health's multi-brand strategy, including Teladoc, Livongo, and BetterHelp, allows it to address various segments of the virtual healthcare market.

Who Are TDOC's Competitors?

TDOC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TDOC's Key Strengths?

Established brand recognition in the telehealth market.

• Comprehensive service portfolio covering a wide range of medical conditions.
• Extensive network of physicians, therapists, and other healthcare professionals.
• Proprietary technology platform and data analytics capabilities.

What Are TDOC's Weaknesses?

Negative profit margin indicates challenges with profitability.

• High beta suggests high volatility compared to the broader market.
• Dependence on membership fees and consultation fees for revenue generation.
• Intense competition in the telehealth market.

What Could Drive TDOC Stock Higher?

Potential partnerships with major healthcare providers to expand market reach.

• Expansion into new international markets to tap into global demand for telehealth services.
• Increasing adoption of telehealth services by employers and health plans.
• Growing demand for mental health services driving growth in the BetterHelp platform.

What Are the Key Risks for TDOC?

Financial-distress signal — its Altman Z-Score of -7.29 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-13.1%) — the business is not currently generating profit on shareholder capital.
• Increasing competition from other telehealth providers could erode market share.
• Changes in healthcare regulations and reimbursement policies could impact revenue.
• Data security and privacy concerns could damage reputation and lead to regulatory penalties.
• Negative profit margin poses a risk to long-term financial sustainability.

What Are the Growth Opportunities for TDOC?

• Expansion of Chronic Condition Management Programs: Teladoc Health has a significant opportunity to expand its chronic condition management programs, particularly for conditions like diabetes, hypertension, and chronic kidney disease. The prevalence of these conditions is increasing globally, creating a large and growing market for virtual care solutions. By leveraging its Livongo platform and integrating advanced data analytics, Teladoc Health can provide personalized and effective chronic condition management programs, driving revenue growth and improving patient outcomes.
• Increased Adoption of Mental Health Services: The demand for mental health services is on the rise, driven by increasing awareness of mental health issues and a shortage of mental health professionals. Teladoc Health's BetterHelp platform is well-positioned to capitalize on this trend by providing convenient and affordable access to mental health therapy. By expanding its network of therapists and offering a wider range of mental health services, Teladoc Health can attract new customers and increase revenue. The global mental health market is projected to reach $537.98 billion by 2030.
• Partnerships with Health Systems and Payers: Teladoc Health can drive growth by forming strategic partnerships with health systems and payers. These partnerships can provide access to a larger patient base and integrate Teladoc Health's services into existing healthcare delivery systems. By collaborating with established healthcare providers, Teladoc Health can enhance its credibility and expand its market reach. Many health systems are actively seeking to expand their telehealth capabilities, creating a favorable environment for partnerships.
• International Expansion: Teladoc Health has the opportunity to expand its services into new international markets. The demand for telehealth services is growing globally, driven by similar factors as in the United States, such as increasing healthcare costs and a shortage of healthcare professionals. By adapting its services to meet the specific needs of different countries, Teladoc Health can tap into new revenue streams and establish a global presence. The global telehealth market is projected to reach $55.6 billion by 2027.
• Integration of Artificial Intelligence and Machine Learning: Teladoc Health can leverage artificial intelligence (AI) and machine learning (ML) to enhance its services and improve patient outcomes. AI and ML can be used to personalize treatment plans, predict patient needs, and automate administrative tasks. By integrating these technologies into its platform, Teladoc Health can improve the efficiency and effectiveness of its services, attracting new customers and increasing customer retention. The integration of AI in healthcare is projected to reach $34.97 billion by 2030.

What Are TDOC's Competitive Advantages?

• Established brand recognition and reputation in the telehealth market.
• Extensive network of physicians, therapists, and other healthcare professionals.
• Comprehensive service portfolio covering a wide range of medical conditions.
• Proprietary technology platform and data analytics capabilities.

What Does TDOC Do?

Teladoc Health, Inc., established in 2002 and headquartered in Purchase, New York, has evolved into a leading provider of virtual healthcare services. Originally known as Teladoc, Inc., the company rebranded to Teladoc Health, Inc. in August 2018 to reflect its expanded service offerings. The company's core business revolves around delivering a wide array of telehealth solutions, including primary and specialty care, chronic condition management, expert medical services, and mental health support. These services are accessible to a diverse clientele, including employers, health plans, hospitals, health systems, insurance companies, and individual members. Teladoc Health operates through a multi-brand strategy, leveraging the Teladoc, Livongo, and BetterHelp brands to cater to different segments of the virtual healthcare market. The Teladoc platform focuses on on-demand, episodic care, while Livongo specializes in chronic condition management programs for conditions like diabetes and hypertension. BetterHelp provides direct-to-consumer mental health services. This comprehensive approach allows Teladoc Health to address a broad spectrum of healthcare needs through virtual channels, positioning it as a key player in the transformation of healthcare delivery.

What Products and Services Does TDOC Offer?

• Provides virtual medical consultations with doctors and specialists.
• Offers remote mental health therapy and counseling services.
• Delivers chronic condition management programs for diseases like diabetes and hypertension.
• Provides expert medical opinions and second opinions.
• Offers telehealth platform and program services to hospitals and health systems.
• Connects patients with healthcare providers through video conferencing and phone calls.
• Provides access to a network of physicians, therapists, and other healthcare professionals.

How Does TDOC Make Money?

• Generates revenue through membership fees from employers and health plans.
• Earns fees for virtual medical consultations and therapy sessions.
• Receives payments for chronic condition management programs.
• Offers subscription-based access to its telehealth platform.

What Industry Does TDOC Operate In?

Teladoc Health operates within the rapidly expanding telehealth industry, which is experiencing significant growth due to factors such as increasing demand for remote healthcare services, advancements in technology, and a growing acceptance of virtual care among patients and providers. The market is competitive, with numerous players offering telehealth solutions, including established healthcare providers and emerging technology companies. Teladoc Health differentiates itself through its comprehensive service portfolio, established brand recognition, and extensive network of providers. The industry is expected to continue growing at a rapid pace, driven by ongoing trends in healthcare consumerization and the increasing need for cost-effective and accessible care.

Who Are TDOC's Key Customers?

• Employers who offer Teladoc Health services as a benefit to their employees.
• Health plans that incorporate Teladoc Health into their provider networks.
• Hospitals and health systems that use Teladoc Health's platform to expand their telehealth capabilities.
• Individual members who subscribe to Teladoc Health's services directly.

Wall Street analysts project Teladoc Health, Inc. revenue of about $2.44B for fiscal 2026, with EPS near $-0.87. The estimate reflects 14 contributing analysts.

Teladoc Health, Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 1.1% above estimates on average.

Teladoc Health, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -7.29 places it in the distress zone, a signal of elevated financial risk.

Return on equity for Teladoc Health, Inc. stands at -13.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -6.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 18.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.83 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -14.3%, the inverse of the P/E and a quick read on earnings relative to price.

Teladoc Health, Inc. (TDOC) Valuation Context

Valued at $1.18B, TDOC is classified as a small-cap stock. Relative to its peer group, TDOC's quantitative score of 16/100 is below the peer average of 81/100.

TDOC Revenue & Earnings Trend

In Q2 2026, TDOC generated $606.9M in top-line revenue, marking a sequential decrease of 1.1%. The company recorded a net loss of $38.9M, with diluted EPS of $-0.21. Revenue has contracted over three consecutive quarters, which investors in this small-cap Healthcare stock should monitor closely. Across the four most recent quarters, TDOC averaged $-0.25 in diluted EPS.

Company Profile

Teladoc Health, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in New York, US. The company is led by CEO Charles Divita. TDOC has traded publicly since 2015.

TDOC Financials

TDOC Latest News

TDOC Analyst Consensus

TDOC MoonshotScore

Latest Teladoc Health, Inc. Analysis

TDOC Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources